{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:08:25Z","timestamp":1791608905782,"version":"4.3.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,8,8]],"date-time":"2011-08-08T00:00:00Z","timestamp":1312761600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Dementia is a major and increasing health problem worldwide. This study aims to investigate dementia treatment strategies among physicians specialised in complementary and alternative medicine (CAM) by analysing prescribing patterns and comparing them to current treatment guidelines in Germany.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Twenty-two primary care physicians in Germany participated in this prospective, multicentre observational study. Prescriptions and diagnoses were reported for each consecutive patient. Data were included if patients had at least one diagnosis of dementia according to the 10th revision of the International Classification of Diseases during the study period. Multiple logistic regression was used to determine factors associated with a prescription of any anti-dementia drug including <jats:italic>Ginkgo biloba<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>During the 5-year study period (2004-2008), 577 patients with dementia were included (median age: 81 years (IQR: 74-87); 69% female). Dementia was classified as unspecified dementia (57.2%), vascular dementia (25.1%), dementia in Alzheimer's disease (10.4%), and dementia in Parkinson's disease (7.3%). The prevalence of anti-dementia drugs was 25.6%. The phytopharmaceutical <jats:italic>Ginkgo biloba<\/jats:italic> was the most frequently prescribed anti-dementia drug overall (67.6% of all) followed by cholinesterase inhibitors (17.6%). The adjusted odds ratio (AOR) for receiving any anti-dementia drug was greater than 1 for neurologists (AOR = 2.34; CI: 1.59-3.47), the diagnosis of Alzheimer's disease (AOR = 3.28; CI: 1.96-5.50), neuroleptic therapy (AOR = 1.87; CI: 1.22-2.88), co-morbidities hypertension (AOR = 2.03; CI: 1.41-2.90), and heart failure (AOR = 4.85; CI: 3.42-6.88). The chance for a prescription of any anti-dementia drug decreased with the diagnosis of vascular dementia (AOR = 0.64; CI: 0.43-0.95) and diabetes mellitus (AOR = 0.55; CI: 0.36-0.86). The prescription of <jats:italic>Ginkgo biloba<\/jats:italic> was associated with sex (female: AOR = 0.41; CI: 0.19-0.89), patient age (AOR = 1.06; CI: 1.02-1.10), treatment by a neurologist (AOR = 0.09; CI: 0.03-0.23), and the diagnosis of Alzheimer's disease (AOR = 0.07; CI: 0.04-0.16).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This study provides a comprehensive analysis of everyday practice for treatment of dementia in primary care in physicians with a focus on CAM. The prescribing frequency for anti-dementia drugs is equivalent to those found in other German studies, while the administration of <jats:italic>Ginkgo biloba<\/jats:italic> is significantly higher.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2377-11-99","type":"journal-article","created":{"date-parts":[[2011,8,9]],"date-time":"2011-08-09T18:17:09Z","timestamp":1312913829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Prescribing patterns in dementia: a multicentre observational study in a German network of CAM physicians"],"prefix":"10.1186","volume":"11","author":[{"given":"Elke","family":"Jeschke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ostermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horst C","family":"Vollmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Tabali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Schad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Matthes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,8]]},"reference":[{"key":"511_CR1","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","volume":"366","author":"CP Ferri","year":"2005","unstructured":"Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, et al: Global prevalence of dementia: a Delphi consensus study. Lancet. 2005, 366: 2112-2117.","journal-title":"Lancet"},{"key":"511_CR2","unstructured":"Deutsche Alzheimer Gesellschaft e.V.: Die Epidemiologie der Demenz. [http:\/\/www.deutsche-alzheimer.de\/fileadmin\/alz\/pdf\/factsheets\/FactSheet01.pdf]"},{"key":"511_CR3","volume-title":"Alzheimer's Disease International","author":"A Wimo","year":"2010","unstructured":"Wimo A, Prince M: World Alzheimer Report 2010: the global economic impact of dementia. Alzheimer's Disease International. 2010, [http:\/\/www.alz.org\/documents\/national\/World_Alzheimer_Report_2010_Summary(1).pdf]"},{"key":"511_CR4","unstructured":"Krankheitskosten: Deutschland, Fachserie 12 Reihe 7.2. Statistisches Bundesamt: Gesundheit. 2010, , [http:\/\/www.gbe-bund.de\/gbe10\/owards.prc_show_pdf?p_id=13548&p_sprache=d&p_uid=&p_aid=&p_lfd_nr=1]"},{"key":"511_CR5","first-page":"CD005593","volume-title":"Cochrane Database Syst Rev","author":"J Birks","year":"2006","unstructured":"Birks J: Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev. 2006, CD005593-"},{"key":"511_CR6","first-page":"CD003154","volume-title":"Cochrane Database Syst Rev","author":"R McShane","year":"2006","unstructured":"McShane R, Areosa Sastre A, Minakaran N: Memantine for dementia. Cochrane Database Syst Rev. 2006, CD003154-"},{"key":"511_CR7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.7326\/0003-4819-148-5-200803040-00009","volume":"148","author":"P Raina","year":"2008","unstructured":"Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M, Booker L, Oremus M: Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med. 2008, 148: 379-397.","journal-title":"Ann Intern Med"},{"key":"511_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/ebmh.11.4.113","volume":"11","author":"H Kaduszkiewicz","year":"2008","unstructured":"Kaduszkiewicz H, Hoffmann F: Review: cholinesterase inhibitors and memantine consistently but marginally improve symptoms of dementia. Evid Based Ment Health. 2008, 11: 113-10.1136\/ebmh.11.4.113.","journal-title":"Evid Based Ment Health"},{"key":"511_CR9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/ptr.2656","volume":"23","author":"BH May","year":"2009","unstructured":"May BH, Lit M, Xue CC, Yang AW, Zhang AL, Owens MD, Head R, Cobiac L, Li CG, Hugel H, Story DF: Herbal medicine for dementia: a systematic review. Phytother Res. 2009, 23: 447-459. 10.1002\/ptr.2656.","journal-title":"Phytother Res"},{"key":"511_CR10","first-page":"CD003803","volume-title":"Cochrane Database Syst Rev","author":"R McCarney","year":"2003","unstructured":"McCarney R, Warner J, Fisher P, Van Haselen R: Homeopathy for dementia. Cochrane Database Syst Rev. 2003, CD003803-"},{"key":"511_CR11","first-page":"877","volume":"4","author":"XJ Li","year":"2009","unstructured":"Li XJ, Zhang HY: Potential anti-dementia agents in traditional Chinese medicine. Nat Prod Commun. 2009, 4: 877-886.","journal-title":"Nat Prod Commun"},{"key":"511_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1528-1167.2006.00424.x","volume":"47","author":"SL Harms","year":"2006","unstructured":"Harms SL, Garrard J, Schwinghammer P, Eberly LE, Chang Y, Leppik IE: Ginkgo biloba use in nursing home elderly with epilepsy or seizure disorder. Epilepsia. 2006, 47: 323-329. 10.1111\/j.1528-1167.2006.00424.x.","journal-title":"Epilepsia"},{"key":"511_CR13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/978-3-540-72548-0_11","volume-title":"Arzneiverordnungsreport 2007","author":"U Schwabe","year":"2008","unstructured":"Schwabe U: [Antidementiva]. Arzneiverordnungsreport 2007. Edited by: Schwabe U, Paffrath D. 2008, Heidelberg: Springer Medizin Verlag, 313-316."},{"key":"511_CR14","first-page":"CD003120","volume-title":"Cochrane Database Syst Rev","author":"J Birks","year":"2007","unstructured":"Birks J, Grimley Evans J: Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev. 2007, CD003120-"},{"key":"511_CR15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000213167","volume":"16","author":"P Baurle","year":"2009","unstructured":"Baurle P, Suter A, Wormstall H: Safety and effectiveness of a traditional ginkgo fresh plant extract - results from a clinical trial. Forsch Komplementmed. 2009, 16: 156-161. 10.1159\/000213167.","journal-title":"Forsch Komplementmed"},{"key":"511_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1471-2318-10-14","volume":"10","author":"S Weinmann","year":"2010","unstructured":"Weinmann S, Roll S, Schwarzbach C, Vauth C, Willich SN: Effects of Ginkgo biloba in dementia: systematic review and meta-analysis. BMC Geriatr. 2010, 10: 14-10.1186\/1471-2318-10-14.","journal-title":"BMC Geriatr"},{"key":"511_CR17","unstructured":"Ginkgohaltige Pr\u00e4parate bei Alzheimer Demenz. Final-Report. IQWIG. 2008, [http:\/\/www.iqwig.de\/download\/A05-19B_Abschlussbericht_Ginkgohaltige_Praeparate_bei_Alzheimer_Demenz.pdf]"},{"key":"511_CR18","volume-title":"D\u00fcsseldorf: Deutsche Gesellschaft f\u00fcr Allgemeinmedizin und Familienmedizin (DEGAM)","author":"HC Vollmar","year":"2008","unstructured":"Vollmar HC, Mand P, Butzlaff ME: [Demenz DEGAM-Leitlinie Nr.12]. D\u00fcsseldorf: Deutsche Gesellschaft f\u00fcr Allgemeinmedizin und Familienmedizin (DEGAM). 2008, [http:\/\/leitlinien.degam.de\/index.php?id=247]"},{"key":"511_CR19","unstructured":"Psychotherapie und Nervenheilkunde: S3- Leitlinie Demenzen. Deutsche Gesellschaft f\u00fcr Neurologie und Deutsche Gesellschaft f\u00fcr Psychiatrie . 2009, [http:\/\/www.dgn.org\/images\/stories\/dgn\/leitlinien\/ll_demenz\/ll-demenz-lang-170210.pdf]"},{"key":"511_CR20","first-page":"41","volume":"86","author":"HC Vollmar","year":"2010","unstructured":"Vollmar HC, Abholz HH, Egidi G, Wilm S: [Quo Vadis Dementia? Similarities and Differences Between Specialist and Family Medicine Guideline]. Zeitschrift f\u00fcr Allgemeinmedizin. 2010, 86: 41-53.","journal-title":"Zeitschrift f\u00fcr Allgemeinmedizin"},{"key":"511_CR21","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","volume":"282","author":"MD Cabana","year":"1999","unstructured":"Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR: Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999, 282: 1458-1465. 10.1001\/jama.282.15.1458.","journal-title":"JAMA"},{"key":"511_CR22","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1046\/j.1525-1497.1997.07122.x","volume":"12","author":"DK Freeborn","year":"1997","unstructured":"Freeborn DK, Shye D, Mullooly JP, Eraker S, Romeo J: Primary care physicians' use of lumbar spine imaging tests: effects of guidelines and practice pattern feedback. J Gen Intern Med. 1997, 12: 619-625. 10.1046\/j.1525-1497.1997.07122.x.","journal-title":"J Gen Intern Med"},{"key":"511_CR23","doi-asserted-by":"publisher","first-page":"E348","DOI":"10.1097\/00007632-200108010-00013","volume":"26","author":"H Schers","year":"2001","unstructured":"Schers H, Wensing M, Huijsmans Z, van Tulder M, Grol R: Implementation barriers for general practice guidelines on low back pain a qualitative study. Spine. 2001, 26: E348-353. 10.1097\/00007632-200108010-00013.","journal-title":"Spine"},{"key":"511_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1472-6963-3-8","volume":"3","author":"A Espeland","year":"2003","unstructured":"Espeland A, Baerheim A: Factors affecting general practitioners' decisions about plain radiography for back pain: implications for classification of guideline barriers--a qualitative study. BMC Health Serv Res. 2003, 3: 8-10.1186\/1472-6963-3-8.","journal-title":"BMC Health Serv Res"},{"key":"511_CR25","first-page":"485","volume-title":"Nervenheilkunde","author":"H van den Bussche","year":"2005","unstructured":"van den Bussche H, Kaduszkiewicz H: [Prescription patterns and effectiveness perception of anti-dementia drugs - A comparison between General Practitioners, Neurologists and Psychiatrists]. Nervenheilkunde. 2005, 485-492."},{"key":"511_CR26","first-page":"34","volume-title":"EHK","author":"H Matthes","year":"2008","unstructured":"Matthes H, Tabali M, Jeschke E: Ein Pharmakovigilanzsystem f\u00fcr Arzneimittel der besonderen Therapierichtungen. EHK. 2008, 34-39."},{"key":"511_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00002018-200932080-00007","volume":"32","author":"E Jeschke","year":"2009","unstructured":"Jeschke E, Ostermann T, L\u00fcke C, Tabali M, Kr\u00f6z M, Bockelbrink A, Witt MC, Willich SN, Matthes H: Remedies Containing Asteraceae Extracts: A Prospective Observational Study of Prescribing Patterns and Adverse Drug Reactions in German Primary Care. Drug Saf. 2009, 32: 1-16. 10.2165\/00002018-200932010-00001.","journal-title":"Drug Saf"},{"issue":"5","key":"511_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000235239","volume":"16","author":"E Jeschke","year":"2009","unstructured":"Jeschke E, Ostermann T, Tabali M, Bockelbrink A, Witt CM, Willich SN, Matthes H: Diagnostic profiles and prescribing patterns in everyday anthroposophic medical practice--a prospective multi-centre study. Forsch Komplementmed. 2009, 16 (5): 325-333. 10.1159\/000235239.","journal-title":"Forsch Komplementmed"},{"key":"511_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1055\/s-2007-1022529","volume":"70","author":"Arbeitsgruppe Erhebung und Nutzung von Sekund\u00e4rdaten der Deutschen Gesellschaft f\u00fcr Sozialmedizin und Pr\u00e4vention","year":"2008","unstructured":"Arbeitsgruppe Erhebung und Nutzung von Sekund\u00e4rdaten der Deutschen Gesellschaft f\u00fcr Sozialmedizin und Pr\u00e4vention, Arbeitsgruppe Epidemiologische Methoden der Deutschen Gesellschaft f\u00fcr Epidemiologie, Deutschen Gesellschaft f\u00fcr Medizinische Informatik, Biometrie und Epidemiologie, Deutschen Gesellschaft f\u00fcr Sozialmedizin und Pr\u00e4vention. : [Good practice of secondary data analysis, first revision]. Gesundheitswesen. 2008, 70: 54-60.","journal-title":"Gesundheitswesen"},{"key":"511_CR30","first-page":"Doc10","volume":"3","author":"E Jeschke","year":"2007","unstructured":"Jeschke E, Schad F, Pissarek J, Matthes B, Albrecht U, Matthes H: [QuaDoSta - ein frei konfigurierbares System zur Unterst\u00fctzung multizentrischer Datenerhebungen in medizinischer Versorgung und Forschung]. GMS Med Inform Biom Epidemiol. 2007, 3: Doc10-","journal-title":"GMS Med Inform Biom Epidemiol"},{"key":"511_CR31","unstructured":"Kassen\u00e4rztliche Bundesvereinigung: Grunddaten zur vertrags\u00e4rztlichen Versorgung. 2008. [http:\/\/www.kbv.de\/publikationen\/2394.html]"},{"key":"511_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2165\/11534320-000000000-00000","volume":"30","author":"J Olsson","year":"2010","unstructured":"Olsson J, Bergman A, Carlsten A, Oke T, Bernsten C, Schmidt IK, Fastbom J: Quality of drug prescribing in elderly people in nursing homes and special care units for dementia: a cross-sectional computerized pharmacy register analysis. Clin Drug Investig. 2010, 30: 289-300. 10.2165\/11534320-000000000-00000.","journal-title":"Clin Drug Investig"},{"key":"511_CR33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1476-072X-9-59","volume":"9","author":"D Koller","year":"2010","unstructured":"Koller D, Eisele M, Kaduszkiewicz H, Schon G, Steinmann S, Wiese B, Glaeske G, van den Bussche H: Ambulatory health services utilization in patients with dementia - Is there an urban-rural difference?. Int J Health Geogr. 2010, 9: 59-10.1186\/1476-072X-9-59.","journal-title":"Int J Health Geogr"},{"key":"511_CR34","unstructured":"[Die Demenzerkrankung - psychologische und medizinische Aspekte]. Landesverband der Alzheimer-Gesellschaften Nordrhein-Westfalen e.V. [http:\/\/www.alzheimer-nrw.de\/files\/downloads\/%DCbersicht%20Demenz.pdf]"},{"key":"511_CR35","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s12603-009-0078-x","volume":"13","author":"F Formiga","year":"2009","unstructured":"Formiga F, Fort I, Robles MJ, Riu S, Sabartes O, Barranco E, Catena J: Comorbidity and clinical features in elderly patients with dementia: differences according to dementia severity. J Nutr Health Aging. 2009, 13: 423-427. 10.1007\/s12603-009-0078-x.","journal-title":"J Nutr Health Aging"},{"key":"511_CR36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/BF03324714","volume":"19","author":"GB Frisoni","year":"2007","unstructured":"Frisoni GB, Canu E, Geroldi C, Brignoli B, Anglani L, Galluzzi S, Zacchi V, Zanetti O: Prescription patterns and efficacy of drugs for patients with dementia: physicians' perspective in Italy. Aging Clin Exp Res. 2007, 19: 349-355.","journal-title":"Aging Clin Exp Res"},{"key":"511_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1055\/s-2004-813937","volume":"67","author":"G Stoppe","year":"2005","unstructured":"Stoppe G, Pirk O, Haupt M: [Treatment of Alzheimer's disease utilising the best available evidence-based medicine -- utopia?]. Gesundheitswesen. 2005, 67: 20-26. 10.1055\/s-2004-813937.","journal-title":"Gesundheitswesen"},{"key":"511_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/YIC.0b013e3283339496","volume":"25","author":"F Hoffmann","year":"2010","unstructured":"Hoffmann F, van den Bussche H, Glaeske G, Kaduszkiewicz H: Eight-year prescription trends of memantine and cholinesterase inhibitors among persons 65 years and older in Germany. Int Clin Psychopharmacol. 2010, 25: 29-36. 10.1097\/YIC.0b013e3283339496.","journal-title":"Int Clin Psychopharmacol"},{"key":"511_CR39","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1017\/S1041610209991530","volume":"22","author":"I Truter","year":"2010","unstructured":"Truter I: Prescribing of drugs for Alzheimer's disease: a South African database analysis. Int Psychogeriatr. 2010, 22: 264-269. 10.1017\/S1041610209991530.","journal-title":"Int Psychogeriatr"},{"key":"511_CR40","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1159\/000278348","volume":"29","author":"F Formiga","year":"2010","unstructured":"Formiga F, Fort I, Robles MJ, Rodriguez D, Regalado P: Lower barthel index scores predict less prescription of pharmacological therapy in elderly patients with Alzheimer disease. Dement Geriatr Cogn Disord. 2010, 29: 198-203. 10.1159\/000278348.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"511_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0168-8510(01)00191-9","volume":"60","author":"J Ruof","year":"2002","unstructured":"Ruof J, Mittendorf T, Pirk O, von der Schulenburg JM: Diffusion of innovations: treatment of Alzheimer's disease in Germany. Health Policy. 2002, 60: 59-66. 10.1016\/S0168-8510(01)00191-9.","journal-title":"Health Policy"},{"key":"511_CR42","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1111\/j.1532-5415.2006.00942.x","volume":"54","author":"RL Nahin","year":"2006","unstructured":"Nahin RL, Fitzpatrick AL, Williamson JD, Burke GL, Dekosky ST, Furberg C: Use of herbal medicine and other dietary supplements in community-dwelling older people: Baseline data from the ginkgo evaluation of memory study. J Am Geriatr Soc. 2006, 54: 1725-1735. 10.1111\/j.1532-5415.2006.00942.x.","journal-title":"J Am Geriatr Soc"},{"key":"511_CR43","first-page":"208","volume":"52","author":"M Hillmer","year":"2006","unstructured":"Hillmer M, Krahn M, Pariser P, Naglie G: Prescribing patterns for Alzheimer disease: survey of Canadian family physicians. Can Fam Physician. 2006, 52: 208-209.","journal-title":"Can Fam Physician"},{"key":"511_CR44","volume-title":"J Psychopharmacol","author":"K Windfuhr","year":"2010","unstructured":"Windfuhr K, Turnbull P, While D, Swinson N, Mehta H, Hadfield K, Hiroeh U, Watkinson H, Dixon C, Flynn S, et al: The incidence and associated risk factors for sudden unexplained death in psychiatric in-patients in England and Wales. J Psychopharmacol. 2010"},{"key":"511_CR45","first-page":"981","volume-title":"Journal of Clinical Nursing","author":"G Meyer","year":"2009","unstructured":"Meyer G, K\u00f6pke S, Haastert B, M\u00fchlhauser B: Restraint use among nursing home residents: cross-sectional study and prospective cohort study. Journal of Clinical Nursing. 2009, 981-990."},{"key":"511_CR46","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s00391-006-0401-7","volume":"39","author":"E Molter-Bock","year":"2006","unstructured":"Molter-Bock E, Hasford J, Pfundstein T: [Psychopharmacological drug treatment in Munich nursing homes]. Z Gerontol Geriatr. 2006, 39: 336-343. 10.1007\/s00391-006-0401-7.","journal-title":"Z Gerontol Geriatr"},{"key":"511_CR47","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2318-9-18","volume":"9","author":"E Mann","year":"2009","unstructured":"Mann E, Kopke S, Haastert B, Pitkala K, Meyer G: Psychotropic medication use among nursing home residents in Austria: a cross-sectional study. BMC Geriatr. 2009, 9: 18-10.1186\/1471-2318-9-18.","journal-title":"BMC Geriatr"},{"key":"511_CR48","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2165\/00002512-200320060-00003","volume":"20","author":"JL Defilippi","year":"2003","unstructured":"Defilippi JL, Crismon ML: Drug interactions with cholinesterase inhibitors. Drugs Aging. 2003, 20: 437-444. 10.2165\/00002512-200320060-00003.","journal-title":"Drugs Aging"},{"key":"511_CR49","first-page":"1042","volume":"18","author":"JL Mann","year":"2003","unstructured":"Mann JL, Evans TS, Taylor RD, Hettich LA, Kildsig N, Simcox D, McKinley WM: The use of medications with known or potential anticholinergic activity in patients with dementia receiving cholinesterase inhibitors. Consult Pharm. 2003, 18: 1042-1049.","journal-title":"Consult Pharm"},{"key":"511_CR50","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1111\/j.1532-5415.2009.02258.x","volume":"57","author":"A Modi","year":"2009","unstructured":"Modi A, Weiner M, Craig BA, Sands LP, Rosenman MB, Thomas J: Concomitant use of anticholinergics with acetylcholinesterase inhibitors in Medicaid recipients with dementia and residing in nursing homes. J Am Geriatr Soc. 2009, 57: 1238-1244. 10.1111\/j.1532-5415.2009.02258.x.","journal-title":"J Am Geriatr Soc"},{"key":"511_CR51","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/pds.1739","volume":"18","author":"M Robinson","year":"2009","unstructured":"Robinson M, Rowett D, Leverton A, Mabbott V: Changes in utilisation of anticholinergic drugs after initiation of cholinesterase inhibitors. Pharmacoepidemiol Drug Saf. 2009, 18: 659-664. 10.1002\/pds.1739.","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-11-99.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2377-11-99\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-11-99","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-11-99.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T15:57:14Z","timestamp":1630511834000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-11-99"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,8]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["511"],"URL":"https:\/\/doi.org\/10.1186\/1471-2377-11-99","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,8]]},"assertion":[{"value":"17 January 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"99"}}